We are a group of technology enthusiasts and medical professionals brought together by the common interest in battling leukaemia and improving the healthcare/medical industries with open-source technologies, and sharing open information about Leukaemia for patients, families and carers. We aim to use our knowledge and skills to create a better world for Leukaemia patients and their families.
We bring together individuals, companies and organizations to create innovative technologies that could be used in the fight against leukaemia and other blood diseases. We are building a network of innovation and collaboration to provide a better future for people and society.
In 2018 Peter Moss, the grandfather of founder & managing director Adam Milton-Barker, was diagnosed terminally ill with Acute Myeloid Leukaemia. One month before his prognosis, Peter was given the all clear in a routine blood test with no signs of Acute Myeloid Leukaemia. Adam was convinced that there must have been signs in the routine blood test that could have identified the disease.
Adam had previous experience with using Artificial Intelligence for breast cancer detection through the Breast Cancer AI project, and wanted to see if this experience could be used to help with the detection of Acute Myeloid Leukaemia.
Adam created the Peter Moss Acute Myeloid & Lymphoblastic Leukaemia AI Research Project, an open-source research project dedicated to creating free technologies focused on the detection of Acute Myeloid & Lymphoblastic Leukaemia. The long term goal of the research project was to work towards Artificial Intelligence that could one day be used for early detection of the Leukaemia, an issue that remains under research globally and unsolved.
In August 2019, after battling Acute Myeloid Leukaemia for one day short of a year, Peter sadly passed away. This was a devastating time for the family, and made Adam determined to continue the research projects so that one day our technology and information could play a direct role in the lives of Leukaemia patients and their families.
In 2020 a non-profit Association in Spain, Asociación de Investigacion en Inteligencia Artificial Para la Leucemia Peter Moss, was created in memory of Peter to allow our group of volunteers to continue our mission. The Association made great progress over the following year and a half: securing collaborations with Lancaster Intelligent, Robotic and Autonomous Systems Centre, Connecting Europe Facility, FIWARE, Barcelona Health Hub, and Catalan IoT Alliance; having success stories published by Connecting Europe Facility and FIWARE; being nominated for the Barcelona Health Hub Best Innovative Initiative Award, and being featured by Intel at Intel Innovation (IntelON) in the Tech for Good: Intel Innovation Keynote.
In November 2021 Adam decided to return to the UK and created Peter Moss Leukaemia MedTech Research CIC to continue our mission to battle Leukaemia with open-information and open-technology.
DISSEMINATION OF INFORMATION
To disseminate information about Leukaemia & related technologies. To be distributed through our online directory, social media channels and events.
Information will include:
COMMUNITY BENEFIT
OPEN-SOURCE TECHNOLOGIES
To develop and publish opensource and free technologies for:
Technologies to include, but not limited to:
COMMUNITY BENEFIT
FREE SUPPORT COMMUNITY
To create an online support community for Leukaemia patients and their families.
COMMUNITY BENEFIT
STUDENT PROGRAM & COURSES
To provide a free student program and free/paid courses focused on using Artificial Intelligence and other modern technologies that can be used in the fight against Leukaemia
COMMUNITY BENEFIT
SOFTWARE DEVELOPMENT & TECH SUPPORT
Paid technical support and web/software development services for the healthcare and medical industries
COMMUNITY BENEFIT
WORKSHOPS/EVENTS & DEMOS
Hosting workshops/events and demonstrations
COMMUNITY BENEFIT
